Skip to main content
Skip to main content
Go to homepage

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer NCI-AHEP0731

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

Description:

For complete study information, please visit clinicaltrials.gov.

Study Status:
Closed
Full IRB Study Title:
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
IRB Study ID:
1038464 -1
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org
Lead Investigator
Steven Kuerbitz, MD

Director, Divisional Research, Shannon E. Wilkes Targeted Therapy Program; The Jeffrey A. Barbour Chair for Pediatric Hematology/Oncology Research and Healing; Pediatric Hematologist-Oncologist
Showers Family Center for Childhood Cancer and Blood DisordersPediatric Stem Cell Transplant Program

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.